Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof

An inhibitor, selective technology, applied in biochemical equipment and methods, sugar derivatives, pharmaceutical formulations, etc., can solve problems such as lack of selectivity, disrupting various cellular processes, etc.

Inactive Publication Date: 2008-06-25
SIMON FRASER UNIVERSITY
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite its effectiveness, the downside of using NAG-thiazolines in complex biological settings is that it lacks selectivity and thus perturbs a variety of cellular processes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
  • Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
  • Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Embodiment 1: Comparative analysis of O-GlcNAc enzyme and β-hexosaminidase catalytic mechanism

[0092] 1.1 Possible catalytic mechanism of O-GlcNAc enzyme

[0093] A logical starting point for designing O-GlcNAc enzyme inhibitors leads one to think about the catalytic mechanism of O-GlcNAc enzymes and β-hexosaminidases. Although the catalytic mechanism of action of human β-hexosaminidases A and B family 20 is well established [78] , the mechanism of O-GlcNAc enzyme family 84 is still unknown. Therefore, the present inventors first elucidated the catalytic mechanism of the human O-GlcNAc enzyme, and secondly used this information to design efficient, cell-permeable, and O-GlcNAc enzymes that are superior to lysosomal β-hexosaminidases. Simple inhibitor with high selectivity.

[0094] There are three real alternative mechanisms for O-GlcNAc enzymes and the glycoside hydrolase family84. The first is an inversion mechanism such as that found for the goose lysozyme ...

Embodiment 2

[0136] Example 2: Design and Synthesis of a First Embodiment of a Selective O-GlcNAc Enzyme

[0137] 2.1 Design of the first embodiment of selective O-GlcNAc enzyme inhibitor

[0138] With the mechanism of the human O-GlcNAc enzyme and by extension other glycoside hydrolase family 84 members established, attention has shifted to using this information in the design of inhibitors with specific properties for this enzyme. Superior selectivity to human lysosomal β-hexosaminidase. Since both β-hexosaminidase and O-GlcNAc enzymes employ a mechanism involving ortho-promotion, NAG-thiazoline was chosen as the backbone, which can be modified to yield the desired selectivity. Three observations provide a starting point for the design of such inhibitors. The first is that the slope of the Taft-like assay for lysosomal enzymes is much larger than that measured for O-GlcNAc enzymes, thus suggesting that the bulk of the N-acyl group may be a determining factor in substrate recognitio...

Embodiment 3

[0180] Example 3: Design and implementation of a second embodiment of a selective O-GlcNAc enzyme inhibitor synthesis

[0181] 3.1 Design of the second class of selective O-GlcNAc inhibitors

[0182] Based on the above observations, modifications were made on the N-acyl side chain of PUGNAc to generate a second embodiment of a potent and selective O-GlcNAc enzyme inhibitor based on another inhibitor backbone. Such inhibitors can have different pharmacokinetic properties and are an important tool for analyzing the effects of O-GlcNAc post-translational modifications at the cellular and organismal level.

[0183] 3.2 Synthesis of a second embodiment of a selective O-GlcNAc enzyme inhibitor

[0184] The synthesis of a series of six inhibitors using PUGNAc as the backbone is outlined in Scheme 3.

[0185] Start with readily available hydrochloride 10 [93] , introducing a Boc group for protecting the amine moiety, to generate the tetraacetate 11 [94] (Route 3). With the re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention comprises compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions containing the compounds or prodrugs of the compounds. The invention also comprises animal models and methods of making the animal models for studying diseases and disorders related to deficiency or overexpression of O-GIcNAcase, accumulation or deficiency of O-GIcNAc, and treatment of such diseases and disorders. The invention also comprises methods of treating such diseases and disorders. The invention also comprises methods of making the compounds, and methods of making selective glycosidase inhibitors.

Description

[0001] related application [0002] This application claims priority to US Provisional Patent Application No. 60 / 656,878, filed March 1, 2005, which is incorporated herein by reference. technical field [0003] The present application relates to a compound selectively inhibiting glycosidase, a preparation method and use of the inhibitor. Background technique [0004] Many cellular proteins—both nuclear and cytoplasmic—are translated by the addition of the monosaccharide 2-acetylamino-2-deoxy-β-D-glucopyranoside (β-N-acetylglucosamine) Post-modified, the monosaccharide is attached to the protein via an O-glycosidic bond [1] . This modification is commonly referred to as O-linked N-acetylglucosamine or O-GlcNAc. [0005] O-GlcNAc modified proteins have many important cellular functions, including transcription [2-5] , proteasomal degradation [6] and cell signaling [7] . O-GlcNAc is also found in many structural proteins [8-10] . For example, O-GlcNAc has been found i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07H17/00C12Q1/00C07D513/04C07D471/04A61K31/427A61K31/35C07D309/14C07D277/62C07D211/56A61K31/445
CPCC07H17/00A61P3/10A61P25/00A61P25/28A61P35/00A61P43/00
Inventor D·沃卡多G·惠特沃斯M·莫考雷
Owner SIMON FRASER UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com